AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am an Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
Light switches on a blue wall

ESG Focus - Introduction to the UK Energy Savings Opportunity Scheme (ESOS)

Jan 20 2025

Read More
Curiosity line pink background

Raising the Bar for Corporate Governance: The Implications of HKEX’s Proposed Amendments to the Corporate Governance Code

Jan 14 2025

Read More
featured image

Saudi Arabia: Health data under the Personal Data Protection Law

3 minutes Jan 10 2025

Read More